Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00948454 · ClinicalTrials.gov registry record

Research Study on the Effects of Smoking on Arteries

A clinical trial, sponsored by University of Pennsylvania.

Completed
Registry status
105
Enrollment target

NCT00948454: Completed study, sponsored by University of Pennsylvania.

NCT00948454 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 105 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00948454 has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
105 participants
Enrollment target

Study Summary

The current proposal, will elucidate the role of oxidant stress (OS) on arterial function as measured by flow mediated vasodilation. In addition, the investigators will address the hypothesis, that a pro-oxidant might have different degrees of effects on different biological targets, by performing quantitative assessment of the effects of OS on lipids, proteins and DNA.

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2003-01
Est. Completion 2006-06
University of Pennsylvania

1,423 total trials

What the finished NCT00948454 record still lists

NCT00948454 is an observational study that tracks outcomes without assigning an intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00948454 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00948454 about?

NCT00948454 is a clinical study titled "Research Study on the Effects of Smoking on Arteries". The current proposal, will elucidate the role of oxidant stress (OS) on arterial function as measured by flow mediated vasodilation. In addition, the investigators will address the hypothesis, that a pro-oxidant might have different degrees of effects on different biological targets, by performing q...

What is the current status of trial NCT00948454?

This trial is currently completed. The enrollment target is 105 participants. The study started on 2003-01. Estimated completion is 2006-06.

Who is sponsoring clinical trial NCT00948454?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03372317 · 105 participants

    Tau PET in Imaging and Cognition: Healthy Adults From 55-90

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00948454, the US trial registry maintained by the National Library of Medicine. NCT00948454 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.